DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine filing. Monitor the company's next earnings report for any updates on financial performance or strategic direction.
Final — all horizons settled through T+60d
CGON ▲ +3.73% at T+60d
NEUTRAL call ✓ call won +3.73% · α vs SPY -1.05% · entry $66.82 → $69.31
T+1d
-1.90%
call -1.90% · α -1.42%
$65.55
settled 5mo ago
T+5d
+1.32%
call +1.32% · α +0.92%
$67.70
settled 5mo ago
T+20d
-7.38%
call -7.38% · α -12.33%
$61.89
settled 4mo ago
T+60d
+3.73%
call +3.73% · α -1.05%
$69.31
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
CG Oncology filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. This filing follows the recent appointment of Jim DeTore as CFO, which occurred near the same time as this proxy statement. The filing is routine and contains standard proxy information.
Key Facts
- CG Oncology filed a definitive proxy statement (DEFA14A) for its shareholder meeting.
- The filing follows the recent appointment of Jim DeTore as CFO, which occurred 11 days prior.
- The filing is a standard proxy statement with no indication of an activist campaign or contested vote.
Financial Impact
No immediate financial impact from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177424 |
| Document: 0001193125-26-177424-index-headers.html | 0001193125-26-177424 |
| Document: 0001193125-26-177424-index.html | 0001193125-26-177424 |
| Document: 0001193125-26-177424.txt | 0001193125-26-177424 |
17 reports for CGON
100% Hit rate best @ T+20▲ +26.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Press Release | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | $67.38 (+9.98%) |
Aug 6, 2026 8w ago | 424B5 | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | $67.38 (+9.98%) |
Jul 27, 2026 9w ago | Press Release | $72.62 $78.95 | ▲ +8.72% | ▲ +5.34% | $67.38 (−7.22%) |
Jul 17, 2026 11w ago | Insider Cluster | $71.85 $75.03 | ▲ +4.43% | ▼ −0.02% | $67.38 (−6.22%) |
Jul 16, 2026 11w ago | Court Ruling | $69.50 $74.71 | ▲ +7.50% | ▲ +3.88% | $67.38 (−3.05%) |
Jun 24, 2026 14w ago | 144 | $72.84 $71.12 | ▼ −2.36% | ▼ −2.89% | $67.38 (−7.50%) |
Jun 22, 2026 14w ago | 144 | $65.73 $70.19 | ▲ +6.79% | ▲ +5.63% | $67.38 (+2.51%) |
Jun 12, 2026 16w ago | Institutional Cluster | $59.56 $75.24 | ▲ +26.33% | ▲ +24.55% | $67.38 (+13.13%) |
May 26, 2026 18w ago | 8-K | $61.89 $70.25 | ▲ +13.50% | ▲ +15.45% | $67.38 (+8.87%) |
May 15, 2026 20w ago | Press Release | $66.93 $59.56 | ▼ −11.01% | ▼ −13.13% | $67.38 (+0.67%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Mon (63h 31m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access